The role for immunity testing in our Covid reopening strategy

Newsroom | 9 September 2021


A New Zealand science tech company is talking to the Government about using immunity testing as part of the mix in the planned risk-based border opening strategy. But Delta means it’s very much a moving feast, writes Nikki Mandow.


Professor David Williams is one of those super-clever, super-understated scientists you want on your side in a pandemic.


The sort of person who can explain complicated stuff in a way a layperson can understand. But someone whose research career – including almost 300 peer-reviewed articles in international journals on anything from electrochemistry and trace gas sensor technology, to biomolecules and nanoparticles – is pretty extraordinary.


To read the full article on Orbis Diagnostics in Newsroom click here:

https://www.newsroom.co.nz/what-is-the-role-for-immunity-testing-in-our-covid-reopening-strategy